Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2021

Open Access 01-12-2021 | Levothyroxine | Letter to the Editor

Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”

Authors: Sadettin Öztürk, Ersin Akarsu

Published in: Endocrine | Issue 3/2021

Login to get access

Excerpt

We read the manuscript entitled “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment” with great interest and pleasure [1]. We thought some points should be clarified so we decided to explain the test result discrepancies. İn the article to determine the absorbtion rate in patients with high levels of thyroid-stimulating hormone (TSH) despite receiving adequate doses of levothyroxine; …
Literature
1.
IlginYildirim Simsir, UtkuErdem Soyaltin, AhmetGokhan Ozgen, Levothyroxine absorption test results in patients with TSH elevation resistant to treatment. Endocrine 64, 118–121 (2019)CrossRef
2.
GraceE.Ching Sun et al. The clinical utility of free thyroxine in oral levothyroxine absorption testing. Endocr. Pract. 20, 925–929 (2014)CrossRef
3.
KennethB. Ain et al. Pseudomalabsorption of levothyroxine. JAMA 266, 2118–2120 (1991)CrossRef
Metadata
Title
Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”
Authors
Sadettin Öztürk
Ersin Akarsu
Publication date
01-12-2021
Publisher
Springer US
Keyword
Levothyroxine
Published in
Endocrine / Issue 3/2021
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02808-9

Other articles of this Issue 3/2021

Endocrine 3/2021 Go to the issue

Original Article

Correlation between inflammatory parameters and pituitary–thyroid axis in patients with COVID-19

Meta- Analysis

Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression

Original Article

Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience

Letter to the Editor

Response to Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”

Original Article

The relationship between the level of exercise and hemoglobin A1c in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Letter to the Editor

Graves’ disease following SARS-CoV-2 vaccination
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits